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Mitochondrial outer membrane permeabilization (MOMP) is a critical step in apoptosis and is regulated by Bcl-2 family
proteins. In vitro systems using cardiolipin-containing liposomes have demonstrated the key features of MOMP induced
by Bax and cleaved Bid; however, the nature of the “pores” and how they are formed remain obscure. We found that
mitochondrial outer membranes contained very little cardiolipin, far less than that required for liposome permeabiliza-
tion, despite their responsiveness to Bcl-2 family proteins. Strikingly, the incorporation of isolated mitochondrial outer
membrane (MOM) proteins into liposomes lacking cardiolipin conferred responsiveness to cleaved Bid and Bax.
Cardiolipin dependence was observed only when permeabilization was induced with cleaved Bid but not with Bid or Bim
BH3 peptide or oligomerized Bax. Therefore, we conclude that MOM proteins speciﬁcally assist cleaved Bid in Bax-
mediated permeabilization. Cryoelectron microscopy of cardiolipin-liposomes revealed that cleaved Bid and Bax pro-
duced large round holes with diameters of 25–100 nm, suggestive of lipidic pores. In sum, we propose that activated Bax
induces lipidic pore formation and that MOM proteins assist cleaved Bid in this process in the absence of cardiolipin.
INTRODUCTION
Bcl-2 family proteins are critical regulators of apoptosis,
and their major site of action is on the mitochondrial outer
membrane (MOM) (Cory and Adams, 2002; Kuwana and
Newmeyer, 2003; Youle and Strasser, 2008). They share
multiple BH (Bcl-2 homology) domains (BH1–3) and reg-
ulate apoptosis predominantly by controlling the perme-
ability of the MOM. Proapoptotic Bcl-2 family members
promote permeabilization, which leads to the release of
apoptogenic proteins, including cytochrome c (Liu et al.,
1996), SMAC/DIABLO (Du et al., 2000; Verhagen et al.,
2000), and Omi/HtrA (Suzuki et al., 2001), from the inter-
membrane space. Antiapoptotic family members inhibit
this process. Proapoptotic multidomain Bcl-2 family members
Bax and Bak are essential effectors of mitochondrial outer
membrane permeabilization (MOMP) (Lindsten et al., 2000;
Wei et al., 2001), and when they are activated, they change
the conformation and oligomerize in the membrane to
promote MOMP (Nechushtan et al., 1999, 2001; Antonsson
et al., 2001; Kuwana et al., 2002).
The molecular mechanisms that underlie MOMP have
been a subject of intensive study, because this step is
deemed to have high potential for therapeutic intervention
in cancer (Lowe et al., 2004; Brown and Attardi, 2005; Fesik,
2005; Green and Kroemer, 2005). Once MOMP occurs, cells
permanently cease to proliferate (Xiang et al., 1996;
McCarthy et al., 1997; Chipuk and Green, 2005; Brown et al.,
2007; Knudson and Brown, 2008), except under unusual
circumstances (Colell et al., 2007). However, the molecular
mechanism whereby the MOM is permeabilized upon Bax
and Bak activation remains obscure. Bax-mediated mem-
brane permeabilization has been studied in in vitro liposome
systems that faithfully recapitulate some aspects of MOMP.
Such studies have revealed a size-indiscriminatory release of
contents upon the addition of proapoptotic Bax and caspase-
8–cleaved Bid and inhibition of this release by antiapoptotic
family members (Basanez et al., 2002; Kuwana et al., 2002,
2005; Roucou et al., 2002b; Yethon et al., 2003; Terrones et al.,
2004). It is also established that liposomes require at least 7
mol % of cardiolipin in their membranes to undergo optimal
permeabilization induced by cleaved Bid and Bax (Kuwana
et al., 2002; Yethon et al., 2003; Terrones et al., 2004). The
nature of this permeabilization remains unclear. Some stud-
ies suggest that it may involve the formation of protein-
aceous channels by Bax molecules, either by themselves
(Saito et al., 2000) or together with other MOM-resident
membrane proteins, such as voltage-dependent anion chan-
nel (VDAC) (Shimizu et al., 1999, 2000). However, that dou-
ble knockout mice lacking VDAC isoforms 1 and 3 do not
show the apoptotic defect argues against the involvement
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of these proteins (Baines et al., 2007), and the other studies
suggest that the pores may be lipidic in nature (Basanez et
al., 2002; Hardwick and Polster, 2002; Terrones et al.,
2004).
The physiological relevance of cardiolipin in MOMP,
however, remains controversial. Cardioipin is suggested as a
receptor for Bid in mitochondria (Lutter et al., 2000) and is
shown to facilitate Bax insertion and oligomerization in
liposomes (Lucken-Ardjomande et al., 2008a). In contrast,
some studies conclude that cardiolipin is not required for
Bax-mediated killing of yeast (Iverson et al., 2004; Polcic et
al., 2005), although molecular mechanisms of yeast “death”
induced by Bax may not be mediated through MOMP, or the
mechanism of yeast MOMP may not be the same as that of
mammalian mechanism (Roucou et al., 2002b).
Here, we report on a series of studies investigating the
nature of membrane permeabilization induced by cleaved
Bid and Bax by using vesicle systems. We have developed
proteo-liposome systems that reproduce permeabilization
induced by Bax and cleaved Bid with more physiological
material. These proteo-liposomes are comprised solely of
native MOM components, with cardiolipin present only in
trace amounts or absent. It therefore seems that the MOM
contains at least one factor other than cardiolipin that helps
mediate Bid/Bax-induced membrane permeabilization.
Given that this factor was not extracted by organic solvents,
it is likely proteinaceous. We also found that cardiolipin
dependence was only seen when Bax was activated by
cleaved Bid but not by Bid or Bim BH3 peptide or oligomer-
ized Bax. Thus, the proteinaceous factor may be a “receptor”
for cleaved Bid. Finally, cryoelectron microscopy (cryo-EM)
has revealed pore-like openings in cardiolipin-liposomes
after their permeabilization by cleaved Bid and Bax. These
data provide long-sought visual evidence consistent with a
lipidic pore model, suggested previously based on biochem-
ical observations (Basanez et al., 1999; Kuwana et al., 2002;
Terrones et al., 2004). We conclude that MOM proteins assist
cleaved Bid in inducing Bax-dependent lipidic pore forma-
tion in the MOM.
MATERIALS AND METHODS
Formation of Octylglucoside-Large Unilamellar Vesicles
(OG-LUVs), Reformed Outer Membrane Vesicles (ReOMVs),
and Reformed Light Membrane Vesicles (ReLMVs)
Egg phosphatidylcholine (PC), egg phosphatidylethanolamine (PE), soy
phosphatidylinositol (PI), soy phosphatidylserine (PS), and heart cardiolipin
(CL) in chloroform were obtained from Avanti Polar Lipids (Alabaster, AL)
and were mixed appropriately and dried under argon. The lipid ﬁlm was
resuspended in KKE (10 mM potassium phosphate, pH 7.4, 50 mM KCl, and
1 mM EDTA) buffer containing 2% OG. The suspension was stir-mixed for 1 h
at 4°C and dialyzed against KKE to remove detergent. Before dialysis, ﬂuo-
rescein-dextran was added at 5 mg/ml to the samples to be used in the
dextran release assay. The liposome suspension was mixed with twice the
volume of 70% sucrose in KKE and placed at the bottom of a ﬂoat-up sucrose
step gradient consisting of 32 and 0% sucrose in KKE, and liposomes were
collected at the interface. The liposomes were washed and resuspended in
KKE buffer. OMVs (130 g of protein) were solubilized in 100 l of KKE
containing 4% OG for 1 h at 4°C with mixing, and ReOMVs were formed
following the procedures as described above (Figure 2). For OmpA loading,
OmpA in 2% OG-KKE (50 g) was added to lipids (500 g) resuspended in
2% OG-KKE, detergent-solubilized OMVs (130 g of protein), or LMVs
(130 g of protein). The mixture was stirred for 1 h at 4°C, followed by the
same procedures described above. OMVs and LMVs were isolated from
mitochondria and from endoplasmic reticulum (ER) fractions of Xenopus egg
extracts as reported previously (Kuwana et al., 2002).
Formation of ExOMVs
OMVs (780 g of protein) were mixed with 1 ml of chloroform/methanol (1:1)
after which 1 ml of water was added, and the samples were vortexed. The
suspension was spun at 500  g for 10 min in a tabletop centrifuge, and the
organic solvent layer was discarded. One milliliter of chloroform was added
to the aqueous layer, and the lipids were extracted again. The aqueous
solution containing precipitated membrane proteins was mixed with 1.5 ml of
pentane and dried under argon. Dried proteins were resuspended in 200 l of
8 M urea and centrifuged at 150,000 g for 30 min at 4°C, and the supernatant
was collected. The urea solution was diluted threefold with 4% OG-KKE, and
the mixture was dialyzed against 2% OG-KKE to completely remove the urea.
The dialysate was centrifuged at 150,000  g for 30 min to remove nonrena-
tured precipitates in the pellet. A mixture of 100 g of phospholipids (PC:
PE:PI:PS, 59:23:16:2 mol %) was dried and resuspended with the supernatant
of the dialysate containing refolded membrane proteins. The lipid–protein–
detergent mixture was stir-mixed for 1 h at 4°C, and detergent was removed
to form ExOMVs as described above. The ﬁnal pellet was resuspended in
40–80 l of KKE and used in the dextran release assay.
OmpA Production
Escherichia coli BL21(DE3) cells were transformed with pET3b-OmpA171 and
induced according to the methods described in Pautsch et al. (1999). The
bacterial pellet was sonicated in 20 mM Tris, pH 8.5, and the supernatant was
discarded. The pellet was resuspended in the same buffer plus 2% NP-40 and
spun down to collect the inclusion bodies, which were solubilized in 6 M
guanidine-HCl, 20 mM Tris, pH 8.5, in a shaker at 37°C for 2 h. Solubilized
inclusion bodies were diluted fourfold with 4% OG-KKE and dialyzed in 2%
OG-KKE at 4°C. The purity of the OmpA obtained was 95%, according to a
Coomassie-stained gel.
Generation of Recombinant Bcl-2-Family Proteins, BH3
Peptides, Dextran Release Assays, Protein Assay, and
Lipid Composition Analysis by Thin Layer
Chromatography (TLC)
These experimental procedures were performed as described previously
(Kuwana et al., 2002, 2005), except that, in the dextran release assays, at the
end of the incubation, vesicles were pelleted at 150,000  g for 10 min to
collect the released dextrans in the supernatant. Data shown for each release
assay are representative of 10 independent experiments unless otherwise
stated, and all the bar graphs are presented as mean  SEM.
Protein Identiﬁcation by Mass Spectrometry
The protein bands were excised from Coomassie Blue-stained SDS-polyacryl-
amide gel electrophoresis (PAGE) gels, reduced, and alkylated with iodoac-
etamide and tryptic digest was prepared. Mass spectrometric analysis was
performed using a model 4700 Proteomics Analyzer from Applied Biosystems
(Foster City, CA). This instrument uses matrix-assisted laser desorption/
ionization in conjunction with tandem time-of-ﬂight mass analyzers. The
digest was introduced into the instrument in a crystalline matrix of a-cyano-
4-hydroxycinnamic acid containing 2 mM ammonium citrate to suppress
ionization of matrix clusters. Database searches were performed with Applied
Biosystem’s GPS explorer software that uses the Mascot search engine.
Protein assignments were made on the basis of both mass spectrometry
and tandem mass spectrometry spectra. NCBInr was used for protein
identiﬁcation.
Mass Spectrometry for Cardiolipin Quantiﬁcation
For the internal standards, 5 g of C14 1,1,2,2-tetramyristoyl cardiolipin
(Avanti Polar Lipids) was added as an internal standard to 100 g of OMV
preparations before lipid extraction with CHCl3:MeOH:0.15 M NaCl; 4:2:1,
per vol (Sorice et al., 2004). Lipids were resuspended in chlorofom:methanol:
H2O (10:9:1, per vol) and analyzed in the negative ion mode on a Bruker
Esquire HCT ion trap mass spectrometer electrospray ionization at a ﬂow rate
of 120 l/h and a capillary tension of250 V. Ion fragmentation was induced
by argon as collision gas at a pressure of 8 mbar. [M-2H]2-ions of cardiolipin
were quantiﬁed relative to the internal standard.
Cryo-EM
OG-LUVs were formed as described above but in the absence of ﬂuorescein-
dextrans. Typically, 2 mg of phospholipids were dried, and the ﬁnal pellet
was resuspended in 15 l of KKE to obtain the high concentration that is
required for visualization by cryo-EM. Nontreated OG-LUVs were mixed
with 4 M glutathione transferase to control for the presence of proteins. For
Bax, tBid, and Bcl-xL treatment, OG-LUVs (6 l) were incubated with Bax (3.8
M), N/C-Bid (2.3 M), or Bcl-xL (26 M) in 12 l. The recombinant protein
concentrations were increased by 23- to 30-fold, because of the high concen-
tration of vesicles present in the sample (100 times more than in the
standard dextran release assay). The salt concentration was adjusted by
adding KCl to 40–50 mM. For each time point, 3-l aliquots of each sample
were applied to a C-ﬂat holey carbon ﬁlm (Protochips, Raleigh, NC)
supported on a 400 mesh copper grid. These grids were blotted for 2–4 s
and plunge-frozen in ethane in a humidity (95%)- and temperature (25°C)-
controlled chamber using a Vitrobot automated blotting device (FEI, Eind-
hoven, The Netherlands). Grids were cleaned before vitriﬁcation, using a
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Solarus Plasma Cleaner (25% O2, 75% argon). The vitreous ice grids were
transferred into the electron microscope using a Gatan cryostage, which
maintains the grids at a temperature below 170°C. Transmission electron
microscopy was performed using low dose methods on a Tecnai F20
microscope (FEI, Hillsboro, OR) operating at 120 KeV, and at a nominal
magniﬁcation of between 29,000 and 80,000. Images were acquired
using a Tietz slow scan charge-coupled device camera and the Leginon
software (Suloway et al., 2005).
RESULTS
Extracted OMV Lipids Do Not Support Membrane
Permeabilization by Bid/Bax
N/C-Bid and Bax-mediated permeabilization of liposomes
was earlier shown to be cardiolipin dependent (Kuwana et
al., 2002; Yethon et al., 2003; Terrones et al., 2004). We there-
fore examined the possibility that cardiolipin is required for
the response of native MOMs to N/C-Bid. Cardiolipin
amounts in Xenopus egg OMVs, however, were below the
limits of detection for TLC (Figure 1A), and quantitative
lipid mass spectrometry for cardiolipin revealed the pres-
ence of this lipid at only 0.26 0.14 mol % (n	 5; Figure 1B).
This low level could represent the real amount of cardio-
lipin, or it could theoretically result from minor contamina-
tion of our OMV preparations with inner membranes that
are enriched with cardiolipin.
Next, we determined whether native OMV lipids could
support Bid/Bax-mediated permeabilization. Native OMVs
responded to N/C-Bid without the addition of exogenous
Bax protein, presumably because the MOM already harbors
a Bax-like molecule in the membrane. In contrast, liposomes
formed by the extrusion method from lipids extracted from
OMVs responded poorly to the addition of N/C-Bid and
Bax. As shown previously, the same preparations of recom-
binant N/C-Bid and Bax were able to permeabilize lipo-
somes formed from lipids extracted from whole mitochon-
dria, which contain 7 mol % cardiolipin (Kuwana et al.,
2002) (Figure 1C). That the OMVs responded readily to
N/C-Bid, despite their low content of cardiolipin, suggests
that other OMV components may compensate for the re-
duced amounts of cardiolipin or that the cardiolipin present
in the MOM is concentrated into small functional domains,
as has been suggested for contact sites between the outer
and inner membranes (Ardail et al., 1990; Lutter et al., 2001).
All the reconstituted vesicles reported in this study are listed
in Figure 1D.
ReOMVs with Greatly Reduced Amounts of Cardiolipin
Respond Well to Bid/Bax
To determine biochemically whether MOM components fa-
cilitate Bid/Bax-mediated pore formation, it was necessary
to disassemble the OMV components by using detergent. To
this end, we ﬁrst solubilized OMVs by using OG, removed
OG by dialysis, and then allowed vesicles to form (Figure
Figure 1. OMVs do not contain 7 mol % cardiolipin in their total lipids and the extracted lipids from OMVs do not support Bax-mediated
membrane permeabilization. (A) Lipids were extracted from OMVs and subjected to two-dimensional TLC analysis. Cardiolipin was not
visible in the expected location (circled). (B) Relative abundance of cardiolipin species in Xenopus OMV preparations detected by mass
spectrometry quantiﬁcation. OMVs were prepared and each cardiolipin species (based on differences in their fatty acyl chains) was quantiﬁed
against the internal standard, cardiolipin C14 (see Materials and Methods). Four independently prepared OMV batches and one duplicate
sample were analyzed. Numbers in parenthesis show the abundance of the respective cardiolipin species as the average mole percent of total
phospholipids in the sample. The total cardiolipin content in our Xenopus OMVs was 0.26 0.14 mol % (n	 5). Data shown are representative
of four independent analyses. (C) OMV lipid-liposomes did not show signiﬁcant levels of dextran release. Lipids were extracted from OMVs
(trace amount of cardiolipin) or whole mitochondria (7 mol % cardiolipin), and liposomes were formed by the extrusion method. A dextran
release assay was performed as described in Kuwana et al. (2002). Data shown are representative of two independent experiments. (D) A list
of vesicles used in this study.
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2A). We observed that both endogenous membrane proteins
and lipids assembled into proteo-liposomes, as the detergent
was gradually removed. The resulting proteo-liposomes,
termed ReOMVs, were permeabilized after the addition of a
combination of N/C-Bid and Bax, and this permeabilization
was inhibited by the presence of antiapoptotic Bcl-xL or
Mcl-1, as in cardiolipin-liposomes (Kuwana et al., 2002).
Notably, although the OMVs became permeabilized in the
presence of N/C-Bid alone, the ReOMVs did not, but rather
required both N/C-Bid and Bax. Presumably, this was be-
cause the ReOMVs lacked a Bax-like molecule that is present
in the OMVs but is lost during the solubilization and recon-
stitution process.
To rule out the possibility that nonspeciﬁc membrane
protein loading makes liposomes responsive to Bid/Bax-
mediated permeabilization, we loaded a well-characterized
bacterial outer membrane protein, OmpA (Pautsch and
Schulz, 1998; Pautsch et al., 1999), into liposomes lacking
cardiolipin, and also into detergent-solubilized LMVs,
which consist mainly of ER membranes. As shown in Figure
2, C and E, OmpA loading did not confer Bid/Bax respon-
siveness to noncardiolipin-bearing liposomes generated by
the use of detergent (OG-LUVs; Figure 2A) or ReLMVs.
Instead, OmpA loading was inhibitory in those vesicles at
higher doses. In ReOMVs, however, OmpA loading did not
inhibit dextran release, even though more OmpA was
present with respect to the estimated amount of lipid in
the ReOMVs (Figure 2, D and E). Thus, OmpA does not
interfere with the function of N/C-Bid and Bax. We also
found that exogenous addition of nonpermeabilizing lev-
els of OG (0.001–0.1%) did not affect Bid/Bax-dependent
permeabilization of cardiolipin-liposomes generated by
extrusion method that does not involve detergent (data
not shown). This experiment was to mimic the situation in
which a small amount of OG is present in liposome mem-
branes after dialysis.
We also analyzed the cardiolipin content in ReOMVs by
two-dimensional TLC to rule out the possibility that car-
diolipin is enriched in these vesicles and responsible for
their permeabilization. Cardiolipin was under the detec-
tion limit (data not shown), conﬁrming that the content of
this lipid in ReOMVs is minimal, like that of OMVs. Taken
together, our data suggest that native MOMs have com-
ponents that substitute for cardiolipin, or possibly rear-
range small amounts of this lipid into local domains, to
promote Bid/Bax-induced membrane permeabilization.
Figure 2. OMVs possess components that fa-
cilitate N/C-Bid and Bax-induced membrane
permeabilization. (A) Schematic representa-
tion of the protocol for generating liposomes
by detergent-mediated method (left). Dried
lipids were resuspended in buffer containing
2–4% OG, and liposomes (OG-LUVs) were
formed as detergent was removed by dialysis.
ReOMVs were formed based on the same
principle (right) from detergent-solubilized
OMVs. ReOMVs were made solely from en-
dogenous OMV lipids and proteins. (B)
ReOMVs responded to Bcl-2 family proteins
in the same way that cardiolipin-containing
liposomes do; Bax and N/C-Bid released dex-
trans and the release was inhibited by anti-
apoptotic Bcl-xL or Mcl-1. Note that N/C-Bid
alone did not permeabilize the vesicles. (C)
ReLMVs, generated from detergent-solubi-
lized LMVs, were not permeabilized signiﬁ-
cantly in the presence of N/C-Bid and Bax.
(D) The bacterial outer membrane protein
OmpA did not confer responsiveness to lipo-
somes or ReLMVs. Data shown are represen-
tative of four independent experiments. (E)
OmpA loading did not interfere with the re-
sponsiveness of ReOMVs. (F) Coomassie
Blue-stained SDS-PAGE gel conﬁrms the
loading of membrane proteins in ReLMVs,
ReOMVs 
 OmpA, ReOMVs, and ReLMVs 

OmpA. Prominent proteins such as VDAC (a
doublet in Xenopus) and OmpA are indicated
with arrows.ht
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MOM Proteins Are Sufﬁcient to Confer
Bid/Bax-Responsiveness to Proteo-Liposomes
We next asked whether proteins or lipids are responsible for
Bid/Bax-induced permeabilization. Experiments using pro-
tease treatment were inconclusive, because for unknown
reasons, this treatment led to the loss of both MOM proteins
and endogenous lipids. Thus, we instead used organic sol-
vents to separate MOM proteins from lipids. Endogenous
lipids were extracted from the OMVs as in the experiment
shown in Figure 1C, except that the aqueous phase contain-
ing the precipitated membrane proteins was collected. These
proteins were lyophilized under a stream of argon and then
resuspended in 8 M urea. The urea-denatured membrane
proteins were refolded in 2% OG and then loaded onto
liposomes with a lipid composition that mimicked that of
the OMVs (PC:PE:PI:PS, 59:23:16:2 mol %; Figure 3A); note
that cardiolipin was absent. We found that this strategy led
to the loading of some proteins into the ﬁnal liposomes
(Figure 3B) and that these proteo-liposomes, termed extrac-
tion OMVs (ExOMVs), responded to N/C-Bid and Bax to
the same extent as do ReOMVs and cardiolipin-bearing li-
posomes (Figure 3C). This indicates that the factors relevant
to permeabilization are not organic-solvent extractable, and
likely proteinaceous. Thus, we conclude that cardiolipin is
not required for Bid/Bax-mediated permeabilization of the
native MOM and that under physiological conditions, un-
identiﬁed MOM proteins alone can facilitate this process
without cardiolipin.
Cardiolipin Dependence Is Speciﬁc for N/C-Bid
We investigated whether cardiolipin dependence of lipo-
some permeabilization induced by N/C-Bid and Bax was
because of N/C-Bid or Bax. We made liposomes with no
or 7 mol % cardiolipin and analyzed the release of dex-
trans. Bid or Bim BH3 peptide can activate Bax directly in
our liposome system; however, unlike N/C-Bid, this ac-
tivation did not depend on the presence of cardiolipin
(Figure 4A). Furthermore, octylglucoside-oligomerized Bax
(OG-Bax) showed only a slight dependence on cardiolipin
(Figure 4B). Therefore, we conclude that what is dependent
on cardiolipin for membrane permeabilization is N/C-Bid
but not Bax. It seems that if Bax is activated, it can perme-
abilize membranes containing no cardiolipin. This ﬁnding
suggests that the proteinaceous factor in the ExOMVs likely
cooperates with N/C-Bid, rather than Bax, and that Bax does
not require speciﬁc components in the MOM to permeabilize
once it is activated.
Because a MOM protein called mitochondrial carrier
homologue 2 (Mtch2) has been reported to interact with
cleaved Bid and implicated in MOMP (Grinberg et al.,
2005; Gross, 2005), we identiﬁed MOM proteins around
the size of Mtch2 (33 kDa) present in ReOMVs and
ExOMVs. As shown in Figure 4C, mass spectroscopy
detected Mtch2 in ReOMVs, but not in ExOMVs, sugges-
ting that the proteinaceous factor in ExOMVs is not
Mtch2.
Figure 3. MOM proteins facilitate Bax-medi-
ated membrane permeabilization. (A) Sche-
matic diagram for the generation of ExOMVs.
OMVs were mixed with organic solvents to
extract the lipids. The membrane proteins,
which had partitioned into the aqueous phase,
were denatured in 8 M urea, and then allowed
to refold in detergent by dilution and dialysis.
A mixture of puriﬁed phospholipids (Avanti
Polar Lipids) was mixed with the refolded
proteins in detergent. OG was then removed
by dialysis to allow the formation of proteo-
liposomes composed of MOM proteins and
exogenous phospholipids (ExOMVs). The
lipid composition of PC:PE:PI:PS, 59:23:16:2
mol %, mimics that of OMVs. (B) MOM pro-
teins were loaded in ExOMVs. An aliquot of
the sample from each step was loaded and
stained by Coomassie Blue. (C) ExOMVs were
permeabilized by N/C-Bid and Bax, and this
release was inhibited by Bcl-xL or Mcl-1. Ex-
OMVs exhibited the same characteristics as car-
diolipin-containing liposomes and ReOMVs.
Data shown are representative of ﬁve experi-
ments.
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Cryo-EM Reveals Features of Bid/Bax-mediated
Permeabilization of the Lipid Membrane
To investigate the nature of the “openings” in the mem-
brane, we chose to visualize the membrane by cryo-EM. In
contrast to conventional transmission electron microscopy
(TEM), cryo-EM allows the sample to be captured instanta-
neously in a hydrated state; thus, it is widely applied to
visualize liposomes (Almgren, 2000; Johnsson and Edwards,
2003; Frederik and Hubert, 2005). The drawback of this
technique, however, is that it is not amenable to the study of
larger and more physiologically relevant objects, such as
OMVs or mitochondria (500 nm), as the specimens must
be contained in a thin vitriﬁed ice slab that is penetrable by
the electron beam. We found that OG-LUVs (Figure 2A) are
well suited for cryo-EM because of their small diameter
(50–100 nm). OG-LUVs containing 7 mol % cardiolipin re-
sponded to Bcl-2 family proteins in a manner similar to
LUVs generated by the extrusion method (Kuwana et al.,
2002) (Figure 5A). An earlier study showed that in individ-
ual apoptotic cells, the release of green ﬂuorescent protein-
cytochrome c from mitochondria is complete within 6 min
(Goldstein et al., 2000), but we found the release from lipo-
somes slower, reaching its peak after 1 h (Figure 5B). We
speculate that this is because the liposome system lacks
factors that facilitate Bax translocation and that the associa-
tion of Bax with the liposome membrane is thus limited by
diffusion.
For cryo-EM, OG-LUVs were treated with recombinant
N/C-Bid and Bax (and Bcl-xL) at room temperature and
instantaneously frozen using a Vitrobot, which provides a
temperature- and humidity-controlled environment; it is
crucial to keep the vesicles in an environment close to 100%
humidity to prevent the induction of an osmotic effect by
evaporation during the millisecond between blotting and
Figure 4. Cardiolipin dependence is mainly
conferred by N/C-Bid. (A) Liposomes con-
taining 0 or 7% mol cardiolipin were gener-
ated and dextran release assays were per-
formed with different activators of Bax,
namely, N/C-Bid, Bid BH3 peptide, or Bim
BH3 peptide. Among those, only N/C-Bid
showed cardiolipin dependence. The peptides
alone did not permeabilize liposomes (data
not shown). Data shown are representative of
four experiments. (B) OG-oligomerized Bax
(OG-Bax) permeabilized liposomes in the ab-
sence of cardiolipin to a signiﬁcant degree.
Data shown are representative of two experi-
ments. (C) Mtch2, a reported Bid-binding pro-
tein in the MOM (Grinberg et al., 2005), was
detected in ReOMVs but not in ExOMVs.
ReOMVs and ExOMVs were loaded on to a
SDS-PAGE gel, and proteins were stained by
Coomassie Blue. Predominant bands30-kDa
were subjected to trypsin digestion, and the
proteins were identiﬁed by mass spectrome-
try. Note that Xenopus VDAC (xVDAC) vari-
ants xVDAC1 and 2 do not correspond to the
mammalian VDAC isoforms.
Figure 5. OG-LUVs respond to recombinant Bcl-2
family proteins. (A) Dextrans were released from OG-
LUVs containing 7 mol % cardiolipin. N/C-Bid and Bax
permeabilized the vesicles, and the release was inhib-
ited by the addition of the anti-apoptotic protein Bcl-xL
or Mcl-1. N/C-Bid and Bax-mediated release from OG-
LUVs was cardiolipin dependent (data not shown). (B)
Release from OG-LUVs was monitored at 10, 30, 60, and
120 min. In the presence of Bax (120 nM) and N/C-Bid
(45 nM), the dextran release from a population of vesi-
cles reached a plateau at 1 h. This release was inhibited
when Bcl-xL (1 M) was also present. Data shown are
representative of three independent experiments.
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plunge-freezing (Frederik and Hubert, 2005). Untreated ves-
icles seemed perfectly round and the membrane was smooth
and continuous (Figure 6A). In contrast, vesicles treated
with N/C-Bid and Bax exhibited discontinuity in the mem-
brane, and pore-like structures with diameters of 25–100 nm
became visible over time (Figures 6, B and C, and 7, A and
B). It seems from the images that the pores start to form from
one or more foci in a vesicle and then dilate (Figure 7A). The
presence of Bcl-xL prevented pore formation (Figure 6D),
and the percentage of pored vesicles correlated well with the
dextran release curves (Figures 5B and 7C), arguing strongly
that the pores are a result of the permeabilizing effect of
activated Bax on the membrane. The edges of the pores
seemed smooth or rough, suggestive of a mainly lipidic
composition. Based on the variation in size and shape, the
pores are unlikely to be proteinaceous channels.
Theoretically, the openings we observed might have been
formed by vesicle rupture because of a hydrostatic force
generated upon the formation of thin ice within regions
“weakened” by activated Bax. We therefore carefully chose
ﬁelds in which the vesicles maintained their original mor-
phology and were not under pressure. Also, it is unlikely
that deformation takes place when the specimen freezes
rapidly without ice crystal formation. The large apparent
diameter of the pores was consistent with the observation
that different-sized macromolecules are released, and it is
entirely reasonable to suppose that ﬂuorescein-dextrans es-
cape from these pores. Given that the same pore-like struc-
tures were also seen in cardiolipin-liposomes generated by
the extrusion method (data not shown), we can conclude
that the membrane changes were not caused by residual
detergent.
DISCUSSION
MOMP is a critical step in apoptosis and a logical target for
therapeutic intervention for diseases such as cancer, given
that once MOMP occurs, cells usually cannot recover sufﬁ-
ciently to proliferate, even when caspases are inactivated
(Xiang et al., 1996; McCarthy et al., 1997; Chipuk and Green,
2005). How Bcl-2 family proteins interact with one another
to promote or inhibit apoptosis during MOMP has been
studied extensively, but the ﬁnal membrane permeabiliza-
tion step remains a mystery. Bax and Bak are effector pro-
teins in MOMP and are activated by certain BH3-only pro-
teins. Thus, a synergy between Bax and BH3-only proteins is
observed in in vitro systems (Kuwana et al., 2002; Roucou et
al., 2002a; Roucou et al., 2002b; Yethon et al., 2003; Terrones
et al., 2004). As a result of MOMP, several intermembrane
space proteins are released into the cytoplasm.
In our previous studies, we found that the presence of 7
mol % cardiolipin optimizes the permeabilization of pure
lipid vesicles by N/C-Bid and Bax, but we did not address
the physiological relevance of cardiolipin (Kuwana et al.,
2002). Cardiolipin facilitates Bax insertion, oligomeriza-
tion, and permeabilization of the membrane in liposomes
(Kuwana et al., 2002; Terrones et al., 2004; Lucken-Ardjomande
et al., 2008b) and truncated Bid (a carboxy-terminal portion
after the cleavage) targeting to mitochondria (Lutter et al.,
2000, 2001). In contrast, the physiological relevance of car-
diolipin in Bax-mediated cell death has been questioned by
the studies that use yeast systems (Iverson et al., 2004; Polcic
et al., 2005; Ott et al., 2007). Here, we addressed this question
biochemically. Because OMVs contain little cardiolipin, and
because extracted OMV lipids did not by themselves sup-
Figure 6. N/C-Bid and Bax induce pore-like
structures in the OG-LUV membrane. (A)
Nontreated OG-LUVs seemed perfectly round
and had smooth and continuous membranes.
Vesicles were instantaneously frozen in vitri-
ﬁed ice and visualized by cryo-EM. (B) After a
5-min incubation with N/C-Bid and Bax, the
liposome membranes exhibited regions of ir-
regularity and some pore-like structures were
visible (arrows). (C) After 60 min of incuba-
tion with N/C-Bid and Bax, almost all the
vesicles exhibited membrane abnormalities
(arrows). (D) In the presence of Bcl-xL, the
presence of the pores and abnormal mem-
branes were greatly diminished.
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port permeabilization, we hypothesized that MOM proteins
may act either by substituting for cardiolipin or by arranging
the membrane in such a way that the local concentration of
this lipid is sufﬁciently high to facilitate permeabilization.
Our discovery that proteo-liposomes formed solely from
OMV lipids and proteins (ReOMVs) did respond efﬁciently
to N/C-Bid and Bax supports this idea. However, we could
not rule out the possibility that trace amounts of cardiolipin
were present in ReOMVs and contributed to permeabiliza-
tion, or that some other endogenous lipid(s) mediated this
effect.
Subsequently, we separated OMV proteins and lipids
through organic solvent-based extraction. After the lipids
were extracted, we followed a standard method for purify-
ing and incorporating membrane proteins into a lipid bi-
layer. This approach has been particularly successful in the
study of membrane proteins with a -barrel structure (Sur-
rey and Jahnig, 1992; Pautsch and Schulz, 1998; Pautsch et
al., 1999; Tamm et al., 2004; Arnold et al., 2007; Shanmuga-
vadivu et al., 2007). Our ﬁnding that the resulting ExOMVs
respond to N/C-Bid- and Bax-mediated permeabilization
strongly supports the notion that the responsible factor is
proteinaceous. Moreover, as these vesicles possess no cardi-
olipin, we can conclude that one or more MOM proteins
substitute functionally for cardiolipin rather than rearrang-
ing it to increase the local concentration of the lipid. As
controls, we tested ReLMVs and OmpA-loaded liposomes,
and the inability of these proteo-liposomes to be permeabil-
ized by Bid/Bax argues that the permeabilization we ob-
served in ExOMVs is dependent on speciﬁc proteins present
rather than proteo-liposome formation per se.
Bid or Bim BH3 peptide and Bax together permeabilized
noncardiolipin containing liposomes equally well as cardi-
olipin-containing liposomes. Also, detergent-oligomerized
Bax displayed only slight cardiolipin dependence. These
ﬁndings suggest that N/C-Bid is the component that is
dependent on cardiolipin in our liposome system. Therefore,
the proteinaceous factor that confers responsiveness to N/C-
Bid and Bax might be a “Bid receptor.” A report on an in
vitro liposome system has shown that cleaved Bid induces
binding of Bax and Bcl-xL to the membrane (Billen et al.,
2008). Our putative Bid receptor hypothesis ﬁts with this
scenario. Billen et al. (2008) used tBid, the C-fragment por-
tion of cleaved Bid, which might have mitigated the strict
requirement for cardiolipin like that for N/C-Bid. Still, the
idea of Bid association with the membrane preceding Bax
binding to the membrane agrees with our ﬁnding. Recently,
Gross and colleagues have reported that Mtch2, a MOM
protein, binds to cleaved Bid and regulates MOMP (Grin-
berg et al., 2005; Gross, 2005). This protein might be a good
candidate for our proteinaceous factor; however, we did not
detect Mtch2 in our ExOMVs. Although it might play some
Figure 7. (A) A gallery of pore-bearing ves-
icles and a cartoon illustration of how the
pores may be formed (bottom). Bar, 100 nm.
(B) Views of two permeabilized vesicles (lipo-
some 1 and 2) with tilted angles: 45°, 0°, and

45°. (C) Summary of the number of porous
vesicles over time. The percentages of vesicles
with pores correlated well with dextran-re-
lease shown in Figure 5B. the total number of
counted vesicles is shown in parentheses.
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role in ReOMVs, we suspect that Mtch2 is not essential in
our ExOMV permeabilization. The identity of the factor
together with its physiological relevance and the detailed
molecular mechanisms through which this factor helps Bid
activate Bax will be addressed in the future studies. Our
results also suggest that activated Bax may not require other
speciﬁc components in the lipid bilayer to permeabilize it, so
the critical apoptotic regulations may be at the point of Bax
activation (Leber et al., 2007).
Earlier studies addressing the nature of the Bax pore have
generated conﬂicting evidence, some suggesting that it is
proteinaceous (Shimizu et al., 1999; Saito et al., 2000) and
others that it is lipidic (Basanez et al., 1999, 2002; Terrones et
al., 2004). Although our previous study failed to detect gross
morphological changes in the OMV membranes after they
were treated with N/C-Bid (Kuwana et al., 2002), it was
inconclusive because it relied on conventional TEM, which
requires chemical ﬁxation and dehydration that could de-
stroy subtle membrane changes. We avoided such potential
artifacts in the current study by applying cryo-EM, which
does not require harsh treatment of the vesicles and is able
to capture transient changes. When permeabilized by N/C-
Bid and Bax, the liposomes exhibited pore-like openings at
one or more foci. The ﬁnding that the diameter of these
pores was 25–100 nm accounted for our previous obser-
vation that different-sized dextrans are released from per-
meabilized vesicles (Kuwana et al., 2002). Such pores might
also explain the large channel activity recorded in mitochon-
dria during MOMP (Pavlov et al., 2001; Guihard et al., 2004;
Dejean et al., 2005). Given that we observed a good correla-
tion between the number of vesicles with pores and the
amount of dextran release, we conclude that dextrans escape
through these pores. Based on our images, which reveal
variability in size and relatively smooth but irregular edges,
we propose that the openings induced by activated Bax are
mostly lipidic, consistent with the earlier proposal by Hard-
wick and Polster (2002). The lipidic-pore (or toroidal) model
(Shai, 1999; Sobko et al., 2004) for Bax-dependent membrane
permeabilization has been suggested by the studies using a
Bax 5 peptide (a 34 mer taken from helix 5 of Bax) (Garcia-
Saez et al., 2007; Qian et al., 2008). Indeed, our Bax-pores
seem different from proteinaceous pores formed by a bacte-
rial toxin pneumolysin, which is visualized by cryo-EM
(Tilley et al., 2005). Pneumolysin pore formation is supposed
to follow the barrel stave model because of its -barrel
structure (Tilley and Saibil, 2006). These pores are uniform
in size and the toxin molecules are visible all around the
edges of the pore. We did not see any protein structures in
the vicinity of the Bax pore in our liposomes. Unfortunately,
OMVs cannot be visualized at all by cryo-EM, because of
their large size. ReOMVs are smaller than OMVs and our
preliminary results suggest that the ReOMVs undergo a
membrane destabilization similar to that observed with
OG-LUVs (data not shown). Visualization of pores in such
objects using a more suited EM technique should answer
whether the pores are also present in vivo.
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